presented at cirse 2020 summit

cirse observational studies

The results from the CIRSE observational studies on chemo- and radioembolisation have been published exclusively in CVIR!

Not only are these the first-ever published results from CIRSE sponsored studies, but they also represent the largest cohorts on their respective treatments. Read about the outcomes of CIRT, CIRT-FR and CIREL here!


Scientific Societies Should Start Sponsoring Observational Studies 

Philippe L. Pereira, Thomas Helmberger, Julien Taieb, Valérie Vilgrain & Thierry de Baere


The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis

Philippe L. Pereira, Roberto Iezzi, Riccardo Manfredi, Francesca Carchesio, Zoltan Bánsághi, Elias Brountzos, Stavros Spiliopoulos, Javier J. Echevarria-Uraga, Belarmino Gonçalves, Riccardo Inchingolo, Michele Nardella, Olivier Pellerin, Maria Sousa, Dirk Arnold, Thierry de Baère, Fernando Gomez, Thomas Helmberger, Geert Maleux, Hans Prenen, Bruno Sangro, Bleranda Zeka, Nathalie Kaufmann & Julien Taieb


Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT)

Thomas Helmberger, Rita Golfieri, Maciej Pech, Thomas Pfammatter, Dirk Arnold, Roberto Cianni, Geert Maleux, Graham Munneke, Olivier Pellerin, Bora Peynircioglu, Bruno Sangro, Niklaus Schaefer, Niels de Jong & José Ignacio Bilbao & On behalf of the CIRT Steering Committee & On behalf of the CIRT Principal Investigators


Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France 

Romaric Loffroy, Maxime Ronot, Michel Greget, Antoine Bouvier, Charles Mastier, Christian Sengel, Lambros Tselikas, Dirk Arnold, Geert Maleux, Jean-Pierre Pelage, Olivier Pellerin, Bora Peynircioglu, Bruno Sangro, Niklaus Schaefer, María Urdániz, Nathalie Kaufmann, José Ignacio Bilbao, Thomas Helmberger & Valérie Vilgrain On behalf of the CIRT-FR Principal Investigators




The PAD Day was back for a second time at the CIRSE 2020 Summit with session First@CIRSE featuring the latest data releases in the field and an Innovative Forum. Read the reports from the latest study releases:


Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent 

Michael D. Dake, Fabrizio Fanelli, Aaron E. Lottes, Erin E. O’Leary, Heidi Reichert, Xiaohui Jiang, Weiguo Fu, Osamu Iida, Kan Zen, Marc Schermerhorn, Thomas Zeller & Gary M. Ansel


Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent

Stefan Müller-Hülsbeck, Andrew Benko, Yoshimitsu Soga, Masahiko Fujihara, Osamu Iida, Anvar Babaev, David O’Connor, Thomas Zeller, Daniel D. Dulas, Juan Diaz-Cartelle & William A. Gray



Presented during the Free Paper Session:


Clinical Outcomes of Ambulatory Endovascular Treatment Using 4-French and 6-French Femoral Access Strategies: The Bio4amb Multicentre Trial

Marianne Brodmann, Koen Deloose, Eric Steinmetz, Olivier Regnard, Jens C. Ritter, Ludovic Berger, Johannes B. Dahm, Shirley Jansen, Bibombe P. Mwipatayi, Pascal Desgranges, Klaus Hausegger & Jos C. van den Berg on behalf of the BIO4AMB investigators